Ansell Limited

Australia Country flag Australia
Sector: Medical Supplies
Ticker: ANN
ISIN: AU000000ANN9
Factsheet Factsheet

Market multiple valuation of Ansell Limited ( ANN | AUS)

The most common multiple used in the valuation of stocks is the P/Earnings NTM multiple (Price to Earnings). P/E relates the current share price with the market expectations in terms of Earnings Per Share. This multiple is used to compare a company's market value with its earnings. A company with a high P/Earnings NTM is considered to be overvalued; a company with a low P/Earnings NTM is considered to be undervalued.
The P/Earnings NTM ratio of Ansell Limited is lower than the median of its peer group: around 19.00. The company valuation of Ansell Limited according to these metrics is below the market valuation of its peer group.
The P/Earnings NTM ratio of Ansell Limited is slightly higher than the average of its sector (Medical Supplies): 15.37. The company valuation of Ansell Limited according to these metrics is consistent with the market valuation of its sector.
The P/Earnings NTM ratio of Ansell Limited is slightly higher than its historical 5-year average: 15.9. The (current) company valuation of Ansell Limited is therefore consistent with its valuation average over the last five years.

Valuation
P/E Last P/E (e) 2025P/E NTM
Ansell LimitedFree trialFree trialFree trial
International PeersFree trialFree trialFree trial
Medical Supplies9.5012.6315.37
S&P/ASX 20019.5116.3916.21
Australia-1.5912.2712.34
More...
Beta (Ref: S&P/ASX 200)
Levered betaUnlevered beta
1-Year1.211.26
2-Year1.011.04
3-Year0.971.01
More...
Stock Perf excl. Dividends (in AUD)
ANNS&P/ASX 200Rel. Perf.
Year-to-Date-5.6%0.5%-6.2%
1-Week3.3%0.6%2.8%
1-Month12.8%9.2%3.6%
1-Year27.0%4.9%22.1%
3-Year20.7%14.1%6.7%
5-Year5.5%53.4%-47.9%
More...
International Peers - Ansell Limited
Company NameCtryMarket
Cap.
last (mUSD)
Ansell LimitedAUS3 001
International Peers Median1.02
Elekta ABSWE1 709
APT Medical, Inc.CHN5 507
PharmaNutra S.p.A.ITA-0.00
3M CompanyUSA76 848
Medartis Holding AGCHE-0.00
GPRV Analysis
Created with Highcharts 4.1.70/102/104/106/108/1010/10
Ansell Limited
Intl. Peers
U.S Patents No. 7,882,001 & 8,082,201
More...
Net Sales Chart
Created with Highcharts 4.1.7Millions USD201920202021202220232024 (e)2025 (e)2026 (e)2027 (e)0k1k2k3k
More...
Quotes Chart

1-Year Rebased Stock Chart

  • Ansell Limited
  • S&P/ASX 200
Created with Highcharts 4.1.7Jan '25Sep '24May '25-25%0%25%50%75%
More...

Did you know ?

Multiples charts provide an effective way to quickly analyze a company's valuation over a period of time, and compare it against the valuation of another company, a personal list, or a market index.

About Market Multiples

Many methods can be used to value a company. In reality, business valuation is often a combination of these different approaches. One of the most widely used quantitative methods is the market multiples method. The market valuation is utilized generally as a primary market input, to provide an objective starting point for the valuation. Put simply, this method multiplies the sales or profits of a business by an industry averaged multiplier to calculate the Market Value of the business.
Current multiples include:
- Historical multiples based on standardized financials for the last completed fiscal period: Last, Last Twelve Months (LTM);
- Forward multiples based on consensus estimates for the current fiscal period and next ones: Next Twelve Months (NTM), FY0, FY1.
Current multiples based on per-share metrics (such as earnings per share or book value per share) are calculated using the last closing price, while current multiples based on company-level metrics (such as net sales, EBIT or EBITDA) are calculated using the current market cap or EV (Enterprise Value).